Respiratory Flashcards
Etiology of asthma
airway inflammation
intermittent airflow obstruction, bronchial hyperresponsiveness
Factors: allergens, URIs, exercise, GERD, sinusitis, aspirin/NSAID, obesity, pollutants
Presentation of asthma
episodic wheezing SOB Chest tightness Cough Excess sputum production Symptoms worse at night, smoking
Dx workup of asthma
Spirometry (FEV1, FVC, FEV1/FVC) before and after short acting bronchodilator
Significant reversibility of obstruction by greater than 12% and 200mL in FEV1 or FVC
Treatment staircase for asthma
1: SABA PRN
2: Low-dose ICS
3: Low-dose ICS + LABA or medium dose ICS
4: Med-dose ICS + LABA or medium dose ICS plus LTRA, Theophyline or Ziletron
5: High dose ICS + LABA and consider Omalizumab for patients with allergies
6: High dose ICS + LABA + oral corticosteroid
Severity of asthma in pt. 12 or older
Intermittent: symptoms 2 days a week or less
Mild: greater than 2 days a week but not daily
Moderate: Daily
Severe: Throughout the day
Inhaled corticosteroids: type, MOA, Indication, CI, AE
beclomethasone (QVAR)
fluticasone (flovent)
triamcinolone (Kenalog)
MOA: inhibit release of arachadonic acid, reduces hyperresponsiveness of airway smooth muscle
Indications: COPD, asthma, allergic rhinitis
AE: oropharyngeal candidiasis/thrush, hoarseness
Systemic steroid use in respiratory disorders. type, MOA, Indication, CI, AE
Prednisone, prednisolone, methyl prednisolone
MOA: inhibit release of arachadonic acid
CI: osteoporosis
AE: long term: osteoporosis, increased appetite, glaucoma, impaired wound healing, euphoria, depression, HTN, peripheral edema
Mast cell stabilizer: type, MOA, Indication, CI, AE
cromolyn, nedrocromil
MOA: inhibits mast cell degranulation and release of histamine
Indication: alt therapy for mild persistent asthma (seems to not be used much now)
AE: cough, irritation, taste
Short acting beta agonists (SABA)
type, MOA, Indication, CI, AE
Albuterol, levalbuterol, pirbuterol
MOA: bronchodilation
Indications; acute asthma (rescue use only), COPD, before exercise
CI: shouldn’t have to use more than twice a week.
AE: beta2 muscle cell tremors, tachycardia, hyperglycemia, hypo(kalemia and magnesia)
Long acting beta agonists (LABA)
type, MOA, Indication, CI, AE
salmeterol (serevent); Formoterol FYI: Advair = salmeterol + fluticasone MOA: bronchodilation Indications: asthma, COPD AE: beta2 muscle cell tremors, tachycardia, hyperglycemia, hypo(kalemia and magnesia)
Anticholinergics
Type, MOA, Indication, CI, AE
ipatropium (atrovent): non-selective, short
tiotropium: long acting
MOA: Block vagelly mediated constriction of airway smooth muscle and mucus secretion
Indications: COPD, asthma + COPD, asthma not toleration SABAs
AE: xerostomia, taste (Not regular antiChol AE because inhaled)
Phosphodiesterase inhibitors
Type, MOA, Indication, CI, AE
Theophylline
MOA: Bronchodilator. Exact MOA not clear
Indication: Used to be mainstay of treatment for asthma, replaced by ICS and beta2 agonists
AE: seizures, fatal arrythmias, tachyC
Leukotreine modifiers
Type, MOA, Indication, CI, AE
Zafirlukast
Montelukast (singulair)
Zileuton
MOA: Inhibits dif steps in the arachadonic acid inflam pathway
Indications: Asthma, not for COPD
AE: elevated serum hepatic enzymes, HA, dyspepsia
Common organisms for CAP
Typical: strep pneumo (gram + cocci), H flu (gram - rod)
Atypical: mycoplasma, chlamydia, legionella
Immunocomp: pseudomonas
Viral: staph aureus
Clinical presentation for CAP typical
Sudden onset of high fever Productive cough with purulent sputum pleuritic chest pain Rigors Tachycardia, tachypnea